Results 141 to 150 of about 180,059 (262)

Old disease, new twist

Journal of Hospital Medicine, EarlyView.
Abstract An 81‐year‐old man with a history of high‐grade urothelial carcinoma of the bladder and ureter on treatment with atezolizumab and tiragolumab presented to the emergency department with 5 months of malaise, generalized weakness, and fatigue and 2 weeks of subjective fevers. One month prior to presentation, he received an empiric 9‐day course of
Hadi Roudsari, Gurpreet Dhaliwal, Anand D. Jagannath, Alan H. Baik, Sam Brondfield   +4 more
wiley   +1 more source

Retraction: Protective effects of calorie restriction and 17-β estradiol on cardiac hypertrophy in ovariectomized obese rats. [PDF]

PLoS One
PLOS One Editors.
europepmc   +1 more source

Global Profiling of Protein Lysine Lactylation in Mouse Cardiac Hypertrophy: A Lactylome Analysis. [PDF]

J Cardiovasc Dev Dis
Zhu W, Guo S, Yang Y, Dong Y, Liu C, Chen C.   +5 more
europepmc   +1 more source

Periodontitis and its association with left ventricular geometry and function: A cross‐sectional study

Journal of Periodontology, EarlyView.
Abstract Background This study investigated the cross‐sectional association between periodontal status and left ventricular (LV) geometry and function, an early and prognostically relevant marker of cardiovascular disease. Methods Data were drawn from two population‐based cohorts in the Study of Health in Pomerania (SHIP): SHIP‐START‐2 (N = 2333) and ...
Maja Trost, Till Ittermann, Birte Holtfreter, Christiane Pink, Marcus Dörr, Henry Völzke, Matthias Nauck, Marcello Ricardo Paulista Markus, Thomas Kocher   +8 more
wiley   +1 more source

Differential expression of metabolic genes distinguishes physiological from pathological cardiac hypertrophy. [PDF]

BMC Cardiovasc Disord
Cai X, Lin S, Chen J, Dai Q, Diao Y, Zheng L.   +5 more
europepmc   +1 more source

Congenital short bowel syndrome: Clinical aspects by systematic review

JPGN Reports, EarlyView.
Abstract Objectives Congenital short bowel syndrome (CSBS) is a rare intestinal disorder characterized by inborn shortening of the bowel with mainly mutations in Coxsackie and Adenovirus receptor‐like membrane protein (CLMP) and Filamin A (FLNA) genes.
Barblin Remund, Susanne Schibli, Christiane Sokollik   +2 more
wiley   +1 more source

Exercise-induced adipose tissue ADRB2-PGC1α-FGF21 signaling protects against pathological cardiac hypertrophy. [PDF]

iScience
Tan F, Wang Z, Cheng Y, Jiang P, Liao R, Zheng Z, Duan Q.   +6 more
europepmc   +1 more source

Gymnema sylvestre: Bioactive constituents, health benefits, and emerging applications in nutraceuticals and functional foods

JSFA reports, EarlyView.
Abstract Gymnema sylvestre (Retz.) R.Br. ex‐Schult., commonly known as “gurmar” or “sugar destroyer,” belongs to the Apocynaceae family and is traditionally used in Ayurveda for diabetes management. This review synthesizes ethnomedicinal evidence with contemporary pharmacological studies, to evaluate the therapeutic properties and mechanistic actions ...
Faiza Saeed, Muhammad Tauseef Sultan, Hassan Raza, Ahmad Mujtaba Noman, Nimra Haroon, Entessar Mohammad Al Jbawi   +5 more
wiley   +1 more source

Andrographolide Mitigates DOCA-Salt-Induced Cardiac Hypertrophy by Regulating Calcium-Handling Genes. [PDF]

J Pharm Bioallied Sci
Fadhillah MR, Arozal W, Tjandrawinata RR, Sukmawati D, Monayo ER, Noviana D, Louisa M.   +6 more
europepmc   +1 more source

MEK Inhibitor Associated Airway Injury in an Infant With Noonan Syndrome: A Case Report

The Laryngoscope, EarlyView.
An infant with Noonan syndrome treated with trametinib developed extensive mucosal sloughing of the upper and lower airway, followed by severe supraglottic scarring. Clinicians should consider airway toxicity as a potential adverse effect of MEK inhibitor therapy.
Veronica Drozdowski‐Nuccio, Rachel D. Yoon, Steven Tomasi, Dana M. Thompson, Inbal Hazkani   +4 more
wiley   +1 more source